Optimisation of SARS-CoV-2 culture from clinical samples for clinical trial applications
View ORCID ProfileDominic Wooding, View ORCID ProfileKate Buist, View ORCID ProfileAlessandra Romero-Ramirez, Helen Savage, Rachel Watkins, View ORCID ProfileDaisy Bengey, View ORCID ProfileCaitlin Greenland-Bews, Caitlin R Thompson, View ORCID ProfileNadia Kontogianni, View ORCID ProfileRichard Body, View ORCID ProfileGail Hayward, Rachel L Byrne, Susan Gould, CONDOR Steering Group, Christopher Myerscough, View ORCID ProfileBarry Atkinson, Victoria Shaw, Bill Greenhalf, Emily Adams, View ORCID ProfileAna Cubas-Atienzar, View ORCID ProfileSaye Khoo, View ORCID ProfileTom Fletcher, Thomas Edwards
doi: https://doi.org/10.1101/2024.03.25.24304829
Dominic Wooding
1Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine and Hygiene, Liverpool, United Kingdom
Kate Buist
1Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine and Hygiene, Liverpool, United Kingdom
Alessandra Romero-Ramirez
1Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine and Hygiene, Liverpool, United Kingdom
Helen Savage
2Department of Clinical Sciences, Liverpool School of Tropical Medicine and Hygiene, Liverpool, UK
Rachel Watkins
1Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine and Hygiene, Liverpool, United Kingdom
Daisy Bengey
1Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine and Hygiene, Liverpool, United Kingdom
Caitlin Greenland-Bews
1Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine and Hygiene, Liverpool, United Kingdom
Caitlin R Thompson
1Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine and Hygiene, Liverpool, United Kingdom
Nadia Kontogianni
1Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine and Hygiene, Liverpool, United Kingdom
Richard Body
3Manchester University NHS Foundation Trust, Research and Innovation, Manchester, UK
Gail Hayward
4Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK
Rachel L Byrne
2Department of Clinical Sciences, Liverpool School of Tropical Medicine and Hygiene, Liverpool, UK
Susan Gould
1Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine and Hygiene, Liverpool, United Kingdom
CONDOR Steering Group
3Manchester University NHS Foundation Trust, Research and Innovation, Manchester, UK
Christopher Myerscough
1Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine and Hygiene, Liverpool, United Kingdom
Barry Atkinson
6Research and Evaluation, UK Health Security Agency, Porton Down, Salisbury SP4 0JG, UK
Victoria Shaw
5University of Liverpool, Liverpool, UK
Bill Greenhalf
5University of Liverpool, Liverpool, UK
Emily Adams
1Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine and Hygiene, Liverpool, United Kingdom
Ana Cubas-Atienzar
1Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine and Hygiene, Liverpool, United Kingdom
Saye Khoo
5University of Liverpool, Liverpool, UK
7NIHR Royal Liverpool and Broadgreen CRF, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
Tom Fletcher
2Department of Clinical Sciences, Liverpool School of Tropical Medicine and Hygiene, Liverpool, UK
7NIHR Royal Liverpool and Broadgreen CRF, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
Thomas Edwards
1Centre for Drugs and Diagnostics, Liverpool School of Tropical Medicine and Hygiene, Liverpool, United Kingdom
Article usage
Posted March 26, 2024.
Optimisation of SARS-CoV-2 culture from clinical samples for clinical trial applications
Dominic Wooding, Kate Buist, Alessandra Romero-Ramirez, Helen Savage, Rachel Watkins, Daisy Bengey, Caitlin Greenland-Bews, Caitlin R Thompson, Nadia Kontogianni, Richard Body, Gail Hayward, Rachel L Byrne, Susan Gould, CONDOR Steering Group, Christopher Myerscough, Barry Atkinson, Victoria Shaw, Bill Greenhalf, Emily Adams, Ana Cubas-Atienzar, Saye Khoo, Tom Fletcher, Thomas Edwards
medRxiv 2024.03.25.24304829; doi: https://doi.org/10.1101/2024.03.25.24304829
Optimisation of SARS-CoV-2 culture from clinical samples for clinical trial applications
Dominic Wooding, Kate Buist, Alessandra Romero-Ramirez, Helen Savage, Rachel Watkins, Daisy Bengey, Caitlin Greenland-Bews, Caitlin R Thompson, Nadia Kontogianni, Richard Body, Gail Hayward, Rachel L Byrne, Susan Gould, CONDOR Steering Group, Christopher Myerscough, Barry Atkinson, Victoria Shaw, Bill Greenhalf, Emily Adams, Ana Cubas-Atienzar, Saye Khoo, Tom Fletcher, Thomas Edwards
medRxiv 2024.03.25.24304829; doi: https://doi.org/10.1101/2024.03.25.24304829
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2890)
- Dermatology (248)
- Emergency Medicine (433)
- Epidemiology (12635)
- Forensic Medicine (10)
- Gastroenterology (815)
- Genetic and Genomic Medicine (4498)
- Geriatric Medicine (411)
- Health Economics (719)
- Health Informatics (2877)
- Health Policy (1060)
- Hematology (381)
- HIV/AIDS (913)
- Medical Education (419)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4266)
- Nursing (228)
- Nutrition (626)
- Oncology (2236)
- Ophthalmology (637)
- Orthopedics (256)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (490)
- Public and Global Health (6846)
- Radiology and Imaging (1505)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (378)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)